Rockville, MD, USA, Aug. 16, 2017 -- The Regulatory Affairs Professionals Society (RAPS) has published the updated, 10th edition of Fundamentals of US Regulatory Affairs, the most extensive reference available on regulatory affairs for pharmaceuticals, medical devices, biologics and other healthcare products intended for the US market. The book is an essential reference for anyone responsible for products that must comply with regulations from the US Food and Drug Administration (FDA) and other relevant US agencies.
|
||||||||
The first edition of US Fundamentals was introduced two decades ago and has undergone regular revisions over the years, reflecting changing regulations and new technologies. Fundamentals of US Regulatory Affairs, 10th Edition has been completely updated with information that is current as of May 2017. Notable changes from the previous edition include more detail in areas such as preclinical trials and Good Laboratory Practices, and clinical trials and Good Clinical Practices. New chapters have been added on traceability and supply chain, and biosimilars. In all, the book is comprised of 44 chapters by 53 regulatory experts.
In addition, for the first time, RAPS has also published two sector-specific US fundamentals books, Fundamentals of US Medical Device Regulations and Fundamentals of US Pharmaceutical & Biologics Regulations. Each one presents the same content published in the 10th edition, but only that which is related to either medical devices or pharmaceuticals and biologics, respectively. This allows those who work exclusively in one sector or the other to get all the information that is pertinent to them without additional content that may not be.
The list price for the full 10th edition is $395, while RAPS members get $100 off that price. Each of the sector-specific books is available for $225 list, and $175 for members. All are available in both print and e-book versions.
Since its introduction, US Fundamentals has sold more than 30,000 copies. It is relied upon by regulatory and legal professionals, professors, students, career-changers and FDA staffers as a valued reference, academic textbook and Regulatory Affairs Certification (RAC) study tool.
For more information or to order any of the fundamentals books, visit RAPS.org/fundamentals.
About RAPS
The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. RAPS offers education and training, professional standards, publications, research, knowledge sharing, networking, career development opportunities and other valuable resources, including Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. RAPS is headquartered in suburban Washington, DC, with chapters and affiliates worldwide. www.RAPS.org
###
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/f42a58a7-9328-488d-ba2f-3b0eb765e033
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/14d84e82-492a-4d4d-8719-c14b97005013
Zachary Brousseau Regulatory Affairs Professionals Society (RAPS) 301 770 2920, ext. 245 [email protected]


Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
Robinhood Expands Sports Event Contracts With Player Performance Wagers
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 



